Examination of olopatadine hydrochloride for anti-itching and topical-steroid sparing effects in patients with chronic eczema or dermatitis

Nishinihon Journal of Dermatology

Volumn 71, Issue 5, 2009, Pages 526-530

  Kuniyuki, Shuichi ^a   Yoshida, Yuki ^a   Maekawa, Naoki ^a   Yamanaka, Kazuhosi ^a  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OLOPATADINE; STEROID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ECZEMA; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MEDICAL RESEARCH; PATIENT ASSESSMENT; PRURITUS; SKIN INFLAMMATION; VISUAL ANALOG SCALE;

EID: 70449112720     PISSN: 03869784     EISSN: None     Source Type: Journal    
DOI: 10.2336/nishinihonhifu.71.526     Document Type: Article

References (22)

1. Ikemura T et al: Inhibitory effect of KW-4679, an anti-allergic drug on tachykinin-mediated airway response induced by electric vagal stimulation in guinea pigs. Jpn J Pharmacol 71: 179-182, 1996. (Pubitemid 26235603)
2. Ikemura T et al: KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leucocytes and guinea pig eosinophils. Int Arch Allergy Immunol 110: 57, 1996. (Pubitemid 26116034)
3. European task force on atopic dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 186: 23-31, 1993.
4. Takahashi H et al: Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis. Arch Dermatol Research 300: 291-295, 2008.
5. Takahashi H et al: Effects of bepotastine, cetirizine, fexofenadine and olopatadine on histamine-induced wheal-and flare- response, sedation and psychomotor performance. Clin Exp Dermatol 29: 526-532, 2004. (Pubitemid 39278201)
6. Matsumoto Y et al: The noncompetive antagonism of histamine H1 receptors expressed in Chinese hamster ovary cells by olopatadine hydrochrolide: its potency and molecular mechanism Pharmacology 81: 266-274, 2008.
7. Izu K, Tokura Y: The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis. J Dermatol 32: 776-781, 2005. (Pubitemid 41703752)
8. Tamura T et al: The effecys of olopatadine hydrochrolide on the munber of scratching induced by repeated application of oxazolone in mice. Eur J Pharmacol 524: 149-154, 2005. (Pubitemid 41606828)